Matches in Wikidata for { <http://www.wikidata.org/entity/Q68988169> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q68988169 description "article scientifique publié en 1987" @default.
- Q68988169 description "artículu científicu espublizáu en marzu de 1987" @default.
- Q68988169 description "bài báo khoa học" @default.
- Q68988169 description "im März 1987 veröffentlichter wissenschaftlicher Artikel" @default.
- Q68988169 description "scientific article published on 01 March 1987" @default.
- Q68988169 description "wetenschappelijk artikel" @default.
- Q68988169 description "наукова стаття, опублікована в березні 1987" @default.
- Q68988169 name "Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies" @default.
- Q68988169 name "Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies" @default.
- Q68988169 type Item @default.
- Q68988169 label "Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies" @default.
- Q68988169 label "Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies" @default.
- Q68988169 prefLabel "Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies" @default.
- Q68988169 prefLabel "Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies" @default.
- Q68988169 P1433 Q68988169-3D69E32F-4066-445B-ADE0-58FBF298C4DE @default.
- Q68988169 P1476 Q68988169-4C0DCF06-2604-42C9-BE83-B7924630E428 @default.
- Q68988169 P2093 Q68988169-023E86D3-0FDA-4FD8-96DF-29B495BD7F33 @default.
- Q68988169 P2093 Q68988169-193A3DBA-B531-4660-A512-C97EEE380E06 @default.
- Q68988169 P2093 Q68988169-58DFD21D-4EC6-4E54-B75F-0D5877430650 @default.
- Q68988169 P2093 Q68988169-C8EC3535-E776-48CE-A263-23B6F98DB669 @default.
- Q68988169 P2093 Q68988169-FA5240BC-E94D-4F92-85C2-AD2C2911DFC1 @default.
- Q68988169 P2093 Q68988169-FEEE4FF8-A1B8-4CFC-91B8-386AD7DB5B80 @default.
- Q68988169 P304 Q68988169-D2B0B17C-D3BD-41CE-A7D3-3C4BCE59F4DD @default.
- Q68988169 P31 Q68988169-3C83D38B-72B5-4734-9F55-818550973981 @default.
- Q68988169 P356 Q68988169-B13406D2-89B8-40DF-9E5E-5553F9C14A3B @default.
- Q68988169 P433 Q68988169-16631B57-EC0D-44ED-A4B5-371538DEBFC5 @default.
- Q68988169 P478 Q68988169-854E8B0F-BE9A-4778-BB40-D3369E178F94 @default.
- Q68988169 P577 Q68988169-5195E35F-E0C8-4ADC-96B7-86A44C479EFD @default.
- Q68988169 P698 Q68988169-34855D03-9C8A-4F2F-868E-8BA79A2C2577 @default.
- Q68988169 P921 Q68988169-64C44F6E-EC0B-47C3-B749-E7E94C253A58 @default.
- Q68988169 P356 0168-5597(87)90035-9 @default.
- Q68988169 P698 2435533 @default.
- Q68988169 P1433 Q23933853 @default.
- Q68988169 P1476 "Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies" @default.
- Q68988169 P2093 "B Skarf" @default.
- Q68988169 P2093 "M H Freedman" @default.
- Q68988169 P2093 "M J Taylor" @default.
- Q68988169 P2093 "N K Keenan" @default.
- Q68988169 P2093 "T Gallant" @default.
- Q68988169 P2093 "W J Logan" @default.
- Q68988169 P304 "81-87" @default.
- Q68988169 P31 Q13442814 @default.
- Q68988169 P356 "10.1016/0168-5597(87)90035-9" @default.
- Q68988169 P433 "2" @default.
- Q68988169 P478 "68" @default.
- Q68988169 P577 "1987-03-01T00:00:00Z" @default.
- Q68988169 P698 "2435533" @default.
- Q68988169 P921 Q419618 @default.